Moreover, in dogs with malignant melanoma and undifferentiated sarcoma, treatment with anti-PD-L1 antibody exhibited antitumor efficacy with acceptable safety profiles [29, 30]. This evidence concerns the gene CD274 and undifferentiated (embryonal) sarcoma.